Cargando…

Prevention of neural tube defects in the UK: a missed opportunity

OBJECTIVE: In 1991, the Medical Research Council (MRC) Vitamin Study demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). We aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, JK, Rankin, J, Draper, ES, Kurinczuk, JJ, Springett, A, Tucker, D, Wellesley, D, Wreyford, B, Wald, NJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941168/
https://www.ncbi.nlm.nih.gov/pubmed/26681697
http://dx.doi.org/10.1136/archdischild-2015-309226
_version_ 1782442257727619072
author Morris, JK
Rankin, J
Draper, ES
Kurinczuk, JJ
Springett, A
Tucker, D
Wellesley, D
Wreyford, B
Wald, NJ
author_facet Morris, JK
Rankin, J
Draper, ES
Kurinczuk, JJ
Springett, A
Tucker, D
Wellesley, D
Wreyford, B
Wald, NJ
author_sort Morris, JK
collection PubMed
description OBJECTIVE: In 1991, the Medical Research Council (MRC) Vitamin Study demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). We aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in the UK from 1998 as it had been in the USA. DESIGN: Estimates of NTD prevalence, the preventive effect of folic acid and the proportion of women taking folic acid supplements before pregnancy were used to predict the number of NTD pregnancies that would have been prevented if folic acid fortification had been implemented. SETTING: Eight congenital anomaly registers in England and Wales. MAIN OUTCOME MEASURES: The prevalence of pregnancies with an NTD in the UK and the number of these pregnancies that would have been prevented if folic acid fortification had been implemented. RESULTS: From 1991 to 2012, the prevalence of NTD pregnancies was 1.28 (95% CI 1.24 to 1.31) per 1000 total births (19% live births, 81% terminations and 0.5% stillbirths and fetal deaths ≥20 weeks’ gestation). If the USA levels of folic acid fortification from 1998 onwards had been adopted in the UK, an estimated 2014 fewer NTD pregnancies would have occurred. CONCLUSIONS: Failure to implement folic acid fortification in the UK has caused, and continues to cause, avoidable terminations of pregnancy, stillbirths, neonatal deaths and permanent serious disability in surviving children.
format Online
Article
Text
id pubmed-4941168
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49411682016-07-13 Prevention of neural tube defects in the UK: a missed opportunity Morris, JK Rankin, J Draper, ES Kurinczuk, JJ Springett, A Tucker, D Wellesley, D Wreyford, B Wald, NJ Arch Dis Child Original Article OBJECTIVE: In 1991, the Medical Research Council (MRC) Vitamin Study demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). We aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in the UK from 1998 as it had been in the USA. DESIGN: Estimates of NTD prevalence, the preventive effect of folic acid and the proportion of women taking folic acid supplements before pregnancy were used to predict the number of NTD pregnancies that would have been prevented if folic acid fortification had been implemented. SETTING: Eight congenital anomaly registers in England and Wales. MAIN OUTCOME MEASURES: The prevalence of pregnancies with an NTD in the UK and the number of these pregnancies that would have been prevented if folic acid fortification had been implemented. RESULTS: From 1991 to 2012, the prevalence of NTD pregnancies was 1.28 (95% CI 1.24 to 1.31) per 1000 total births (19% live births, 81% terminations and 0.5% stillbirths and fetal deaths ≥20 weeks’ gestation). If the USA levels of folic acid fortification from 1998 onwards had been adopted in the UK, an estimated 2014 fewer NTD pregnancies would have occurred. CONCLUSIONS: Failure to implement folic acid fortification in the UK has caused, and continues to cause, avoidable terminations of pregnancy, stillbirths, neonatal deaths and permanent serious disability in surviving children. BMJ Publishing Group 2016-07 2015-12-17 /pmc/articles/PMC4941168/ /pubmed/26681697 http://dx.doi.org/10.1136/archdischild-2015-309226 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Original Article
Morris, JK
Rankin, J
Draper, ES
Kurinczuk, JJ
Springett, A
Tucker, D
Wellesley, D
Wreyford, B
Wald, NJ
Prevention of neural tube defects in the UK: a missed opportunity
title Prevention of neural tube defects in the UK: a missed opportunity
title_full Prevention of neural tube defects in the UK: a missed opportunity
title_fullStr Prevention of neural tube defects in the UK: a missed opportunity
title_full_unstemmed Prevention of neural tube defects in the UK: a missed opportunity
title_short Prevention of neural tube defects in the UK: a missed opportunity
title_sort prevention of neural tube defects in the uk: a missed opportunity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941168/
https://www.ncbi.nlm.nih.gov/pubmed/26681697
http://dx.doi.org/10.1136/archdischild-2015-309226
work_keys_str_mv AT morrisjk preventionofneuraltubedefectsintheukamissedopportunity
AT rankinj preventionofneuraltubedefectsintheukamissedopportunity
AT draperes preventionofneuraltubedefectsintheukamissedopportunity
AT kurinczukjj preventionofneuraltubedefectsintheukamissedopportunity
AT springetta preventionofneuraltubedefectsintheukamissedopportunity
AT tuckerd preventionofneuraltubedefectsintheukamissedopportunity
AT wellesleyd preventionofneuraltubedefectsintheukamissedopportunity
AT wreyfordb preventionofneuraltubedefectsintheukamissedopportunity
AT waldnj preventionofneuraltubedefectsintheukamissedopportunity